» Articles » PMID: 14739092

Weight Gain After Transjugular Intrahepatic Portosystemic Shunt is Associated with Improvement in Body Composition in Malnourished Patients with Cirrhosis and Hypermetabolism

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2004 Jan 24
PMID 14739092
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: To search for changes in body composition and energy metabolism associated with the repeatedly observed weight gain of cirrhotic patients after portosystemic shunting.

Methods: Twenty-one patients were studied prospectively before and 6 and 12 months after transjugular intrahepatic portosystemic shunt (TIPS) to assess body cell mass by two independent methods (total body potassium counting: body cell mass determined by TBP, BCMTBP, bioelectric impedance analysis: body cell mass determined by BIA, BCMBIA), muscle mass (anthropometry), resting energy expenditure (REECALO) by indirect calorimetry, and nutritional intake by dietary recall analysis.

Results: Prior to TIPS patients were hypermetabolic in terms of measured vs. predicted REE (REECALO median 1423 (range 1164-1838) vs. REEPRED 1279 (1067-1687) kcal; P<0.05) and their body cell mass was lower (19.1 (10.9-33.4) vs. 31.7 (16.8-47.1) kg; P=0.001). After TIPS body cell mass (BCMBIA) increased to 23.5 (12.7-44.3) (P<0.025) and 25.7 (14.2-39.7) kg (P=0.05) at 6 and 12 months after TIPS and this was confirmed by total potassium counting (BCMTBP before TIPS: 18.8 (10.6-26.7) vs. 22.4 (12.9-28.5) kg at 6 months; P<0.01). Hypermetabolism persisted throughout the study period. Energy and protein intake increased significantly by 26 and 33%.

Conclusions: An increase of prognostically relevant variables body cell and muscle mass contributes to the weight gain after TIPS in malnourished patients with cirrhosis and hypermetabolism.

Citing Articles

TIPS and hepatic encephalopathy in patients with cirrhosis.

Bozon-Riviere P, Rudler M, Weiss N, Thabut D Metab Brain Dis. 2025; 40(2):117.

PMID: 39903376 DOI: 10.1007/s11011-025-01541-w.


Advancements in nutritional diagnosis and support strategies during the perioperative period for patients with liver cancer.

Li X, Liang Y, Huang C, Li S, Cheng L, You C World J Gastrointest Surg. 2024; 16(8):2409-2425.

PMID: 39220056 PMC: 11362955. DOI: 10.4240/wjgs.v16.i8.2409.


Recent developments in the management of ascites in cirrhosis.

Lan T, Chen M, Tang C, Deltenre P United European Gastroenterol J. 2024; 12(2):261-272.

PMID: 38340308 PMC: 10954428. DOI: 10.1002/ueg2.12539.


Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients.

de Felice I, Ridola L, Riggio O, Faccioli J, Nardelli S, Gioia S J Clin Med. 2023; 12(22).

PMID: 38002642 PMC: 10672441. DOI: 10.3390/jcm12227029.


Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.

March C, Thormann M, Geipel S, Sowa J, Barajas Ordonez F, Pech M Sci Rep. 2023; 13(1):17092.

PMID: 37816875 PMC: 10564886. DOI: 10.1038/s41598-023-43938-6.